Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong ... 1 agonist drugs are Novo Nordisk's (NVO) semaglutide - approved to treat Type 2 Diabetes ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.

New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

While all GLP-1 medications share the same fundamental mechanism of action, variations in molecular structure can influence their effectiveness and duration of action. Longer-acting agents like ...

A great current example is medication semaglutide, sold under the brand name Ozempic, which has a chemical structure that was ...

or molecular structure of GLP-1 agonist agent (semaglutide [Ozempic], liraglutide [Victoza], dulaglutide [Trulicity], or exenatide [Byetta, Bydureon]). There was, however, an inverse association ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

Terpenes from the Cannabis sativa plant may be a viable medication for fibromyalgia and post-surgical pain relief, according to ...

Ozempic and Wegovy are both semaglutide ... There's another company called Structure Therapeutics that is also working on a non peptide small molecule, but there are other ones coming along ...